학술논문

Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma
Document Type
Article
Source
In: Cancer Chemotherapy and Pharmacology. (Cancer Chemotherapy and Pharmacology, July 2023, 92(1):15-28)
Subject
Language
English
ISSN
14320843
03445704